Inventor · disambiguated record
Chris Limberakis
Also filed as: LIMBERAKIS CHRIS
15 granted patents·7 pending applications·144 citations·filing 2003–2025
93Inventor score
Top patents by PatentIndex Score
22 records- 0198US10851081B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2020·Granted Dec 1, 2020·12 cites·19 claims
- 0297US11512070B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2020·Granted Nov 29, 2022·11 cites·16 claims
- 0397US10208019B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2017·Granted Feb 19, 2019·50 cites·26 claims
- 0496US10934279B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Mar 2, 2021·9 cites·16 claims
- 0596US10683281B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Jun 16, 2020·8 cites·30 claims
- 0696US10676465B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Jun 9, 2020·8 cites·30 claims
- 0794US12378230B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Aug 5, 2025·1 cites·20 claims
- 0894US10669259B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2018·Granted Jun 2, 2020·13 cites·31 claims
- 0989US9340493B2Hydroxamic acid derivatives useful as antibacterial agentsPFIZER·Filed 2014·Granted May 17, 2016·7 cites·16 claims
- 1088US12319669B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Jun 3, 2025·0 cites·21 claims
- 1187US2025340544A1GLP-1 Receptor Agonists and Uses ThereofPFIZER·Filed 2025·Application pending·0 cites
- 1286US11858916B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2019·Granted Jan 2, 2024·2 cites·20 claims
- 1383US2025257052A1Glp-1 receptor agonists and uses thereofPFIZER·Filed 2025·Application pending·0 cites
- 1482US11802121B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2022·Granted Oct 31, 2023·0 cites·20 claims
- 1581US12331041B2GLP-1 receptor agonists and uses thereofPFIZER·Filed 2023·Granted Jun 17, 2025·0 cites·16 claims
- 1681US7196090B2Kinase inhibitorsWARNER LAMBERT CO·Filed 2003·Granted Mar 27, 2007·23 cites·10 claims
- 1777US2025270196A1GLP-1 Receptor Agonists and Uses ThereofPFIZER·Filed 2025·Application pending·0 cites
- 1872US2021163455A1GLP-1 Receptor Agonists and Uses ThereofPFIZER·Filed 2021·Application pending·0 cites
- 1950US2022387402A1Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseasesPFIZER·Filed 2020·Application pending·0 cites
- 2045US2023045419A1Solid Forms of 2-((4-((S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid, 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-amine SaltPFIZER·Filed 2020·Application pending·0 cites
- 2144US2005096278A1Antibacterial agentsFiled 2004·Application pending·0 cites
- 2238US7524860B2Antibacterial agentsWARNER LAMBERT CO·Filed 2005·Granted Apr 28, 2009·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Chris Limberakis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →